Home/Filings/4/0000950170-25-056395
4//SEC Filing

LANGE LOUIS G 4

Accession 0000950170-25-056395

CIK 0001936258other

Filed

Apr 20, 8:00 PM ET

Accepted

Apr 21, 5:41 PM ET

Size

8.3 KB

Accession

0000950170-25-056395

Insider Transaction Report

Form 4
Period: 2025-04-14
Transactions
  • Exercise/Conversion

    Restricted Stock Unit

    2025-04-1469137 total
    Ordinary Shares (69 underlying)
  • Exercise/Conversion

    Ordinary Shares

    2025-04-14+6928,049 total(indirect: See Footnote)
Footnotes (4)
  • [F1]The shares are held directly by LGLange III Trust DTD10 (the "Trust") for the benefit of the Reporting Person. The Reporting Person inadvertently reported the ownership of 3,102 ordinary shares issued upon vesting of restricted stock units ("RSUs") on March 28, 2025 to his direct holdings. Such ordinary shares are held by the Trust, and this Form 4 reflects the Reporting Person's correct direct and indirect holdings.
  • [F2]Each RSU represents a contingent right to receive one ordinary share.
  • [F3]3,102 RSUs vested upon grant and 69 RSUs vested on April 1, 2025. The remaining RSUs will vest as follows, subject to the Reporting Person's continued service with the issuer as of each of the applicable vesting dates: 69 of the remaining RSUs will vest on May 1, 2025 and 68 of the remaining RSUs will vest on June 1, 2025.
  • [F4]The RSUs were granted on March 26, 2025 as earnout RSUs pursuant to the business combination agreement, dated as of July 25, 2022, by and among the issuer, Frazier Lifesicences Acquisition Corporation, NewAmsterdam Pharma Holding B.V., and NewAmsterdam Pharma Investment Corporation (the "BCA"). The BCA provided that certain optionholders would receive RSUs of the issuer, determined in accordance with a formula set forth in the BCA and for no additional consideration, if a certain clinical development milestone was achieved within five years of the Closing Date. The Reporting Person's right to receive the earnout RSUs became fixed and irrevocable on the Closing Date.

Documents

1 file

Issuer

NewAmsterdam Pharma Co N.V.

CIK 0001936258

Entity typeother

Related Parties

1
  • filerCIK 0001238401

Filing Metadata

Form type
4
Filed
Apr 20, 8:00 PM ET
Accepted
Apr 21, 5:41 PM ET
Size
8.3 KB